Tessera Defense & Homeland Security Inc. (HLSQ) · Oct 13, 2026 · Share issuance
3.47M shares issued — 3.47M shares equal roughly 24.8% of post-issuance shares
Tessera’s share issuance funds its defense pivot, but 3.47M new shares and continued ATM sales materially increase dilution.
Tessera is an early-stage pivot from its former biotech identity into Israeli defense and homeland-security assets, including drone and unmanned-systems testing technology. The broader acquisition strategy was already public; this filing mainly shows how Tessera is paying for it and funding the transition.
The capital structure changed materially. Tessera issued 195,000 restricted shares for an equity interest in MEA and an option to acquire the rest, while Mandragola received 3,278,039 shares through cashless exercises of the DFSL warrant. 〔0〕
| Item | Filing figure | Context |
|---|---|---|
| Acquisition shares issued | 195,000 | About 1.4% of post-issuance shares |
| Warrant shares issued | 3,278,039 | About 23.4% of post-issuance shares |
| Total shares outstanding | 13,983,094 | After these issuances and ATM sales |
| ATM net proceeds | More than $6 million | Average net price about $1.11 per share |
| DFSL interest acquired | 60% | Remaining warrant subject to a 9.99% ownership cap |
The immediate business effect is funding, not operating proof. The filing gives Tessera more capital to pursue its defense acquisitions, but it reports no revenue, contract win, customer deployment, or integration milestone. That means the defense pivot is being financed before the filing demonstrates commercial traction.
Dilution is the main new cost. The 3.47 million shares issued in the period represent roughly 24.8% of the 13.98 million shares now outstanding, based on the filing’s share count. The warrant exercise is cashless, so it brings no fresh cash; the ATM program does provide more than $6 million, but continued equity issuance increases the share base. 〔1〕
The filing reinforces Tessera’s dependence on external capital. Management says it is continuously evaluating capital needs and may temporarily halt ATM sales, which signals flexibility rather than a completed funding plan.
Bottom line: This filing advances Tessera’s defense buildout only by funding and formalizing ownership; it does not yet show operating progress. The measurable change is a much larger share count, making the event genuinely mixed rather than a clean strategic positive.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!